23 Results for "

antiepileptic effect

" in MedChemExpress (MCE) Product Catalog:
Products (23)

23 Results for "antiepileptic effect" in MCE Product Catalog:

584
584 Publications Verification
Cat. No.: HY-10583
CAS No.: 129830-38-2
Purity:  99.94%
Target:  

Organoid ROCK

Research Areas:  

Neurological Disease Cancer

Y-27632 dihydrochloride is an orally active and ATP-competitive ROCK (Rho-kinase) inhibitor (ROCK-I Ki=220 nM; ROCK-II Ki=300 nM). Y-27632 dihydrochloride shows antiepileptic effects .
loading...
    loading...
428
428 Cited Publications
Cat. No.: HY-10583R
CAS No.: 129830-38-2
Research Areas:  

Cancer

Y-27632 dihydrochloride (Standard) is the analytical standard of Y-27632 dihydrochloride. Y-27632 dihydrochloride is an orally active and ATP-competitive ROCK (Rho-kinase) inhibitor (ROCK-I Ki=220 nM; ROCK-II Ki=300 nM). Y-27632 dihydrochloride shows antiepileptic effects .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0106
CAS No.: 102767-28-2
Synonyms: UCB L059
Target:  

DNA Methyltransferase

Research Areas:  

Neurological Disease Cancer

Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10583G
CAS No.: 129830-38-2
Y-27632 dihydrochloride (GMP) is the GMP level of Y-27632 dihydrochloride (HY-10583). GMP guidelines are used to produce Y-27632 dihydrochloride (GMP). GMP small molecules works appropriately as an auxiliary reagent for cell research manufacture. Y-27632 dihydrochloride is an orally active and ATP-competitive ROCK (Rho-kinase) inhibitor with antiepileptic effect .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14948
CAS No.: 194085-75-1
Purity:  99.77%
Synonyms: RWJ-333369
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Carisbamate (RWJ-333369) is an orally active neuromodulator. Carisbamate prevents the development and production of epilep-like discharges and has a neuroprotective effect after in vitro epilepticus-like injury. Carisbamate has good antiepileptic activity in genetic models of generalized and nonconvulsive epilepsy .
loading...
    loading...
Cat. No.: HY-177093
CAS No.: 2244136-58-9
Synonyms: BMS-986368; CC-97489; ABX-1772
Target:  

MAGL FAAH

Research Areas:  

Neurological Disease

Irafamdastat (BMS-986368) (Example 74) is a FAAH and MAGL inhibitor, with IC50s ≤ 100 nM (human FAAH) and 100 nM-1 μM (human MAGL) respectively. Irafamdastat has antiepileptic effect .
loading...
    loading...
Cat. No.: HY-B0106R
CAS No.: 102767-28-2
Synonyms: UCB L059 (Standard)
Levetiracetam (Standard) is the analytical standard of Levetiracetam. This product is intended for research and analytical applications. Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent .
loading...
    loading...
Cat. No.: HY-164964
CAS No.: 2256030-24-5
Target:  

LPL Receptor

Research Areas:  

Neurological Disease

TRV045 is a selective Sphingosine-1-phosphate subtype 1 receptor agonist with no effect on lymphocyte transport. TRV045 has antiepileptic activity .
loading...
    loading...
Cat. No.: HY-105022
CAS No.: 104383-17-7
Purity:  99.82%
Synonyms: R 58735
Target:  

Tau Protein

Research Areas:  

Neurological Disease

Sabeluzole (R 58735), a benzothiazol derivative, has antiischemic, antiepileptic, and cognitive-enhancing properties. Sabeluzole protects rat hippocampal neurons against NMDA- and glutamate-induced neurotoxicity via preventing tau expression. Sabeluzole enhances memory in rats, and prevents the amnesic effect of Chlordiazepoxide. Sabeluzole can be used fro research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-B0106S
CAS No.: 1133229-29-4
Synonyms: UCB L059-d6
Levetiracetam-d6 is the deuterium labeled Levetiracetam. Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent .
loading...
    loading...
Cat. No.: HY-118931
CAS No.: 684645-54-3
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

EF-1502 is a potent and selective GABA transporter inhibitor with GAT1 and BGT1 inhibitory activity. EF-1502 produces a synergistic anti-epileptic effect when used in combination with Tiagabine (HY-B0696), a compound used to suppress epileptic seizures. The dosing combination of EF-1502 exhibited reduced anti-epileptic efficacy and dyskinesia when used with THIP (HY-10232). The mechanism of EF-1502 differs significantly from Tiagabine, suggesting a unique role in the inhibitory strategy .
loading...
    loading...
Cat. No.: HY-176065
CAS No.: 3084825-09-9
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Nav1.2-IN-1 (compound 5i), a 3-(1,2,3,6-tetrahydropyridine)-4-azaindole derivative, is a potent and selective Nav1.2 inhibitor. Nav1.2-IN-1 induces a reduction in the peak amplitude of Nav1.2 currents with an IC50 value of 7.79 μM. Nav1.2-IN-1 exhibits antiepileptic activity. Nav1.2-IN-1 shows high anticonvulsant effect and low neurotoxicity in subcutaneous Pentetrazole (sc-PTZ)-induced epilepsy mode .
loading...
    loading...
Cat. No.: HY-W016509
CAS No.: 488-58-4
epi-Inositol, a inositol analog, is an antidepressant agent. epi-Inositol shows regulatory effects on expression of the most highly regulated gene in the inositol biosynthetic pathway. epi-Inositol shows antiepileptic effect .
loading...
    loading...
Cat. No.: HY-132246
CAS No.: 1338575-41-9
Purity:  98.04%
Target:  

MAGL

Research Areas:  

Neurological Disease

WWL123 analogue-1 is an analogue of WWL123. WWL123 is a potent and selective ABHD6 inhibitor with an IC50 of 430 nM . WWL123 crosses the blood-brain-barrier and inhibits ABHD6 in brain parenchyma. ABHD6 blockade by WWL123 exerts an antiepileptic effect in Pentylenetetrazole (PTZ)-induced epileptiform seizures and spontaneous seizures in R6/2 mice .
loading...
    loading...
Cat. No.: HY-111189
CAS No.: 896117-64-9
Target:  

GlyT

Research Areas:  

Neurological Disease

GSK931145 is a glycine transporter 1 (GlyT1) inhibitor with anti-epileptic activity. GSK931145 exhibits a low minimum effective dose in the maximum electrical stimulation threshold test, indicating that it has a significant anti-epileptic effect. GSK931145 is also suitable as a positron emission tomography (PET) radioligand for quantifying the availability of glycine transporters in the living brain .
loading...
    loading...
Cat. No.: HY-12155
CAS No.: 877316-38-6
Research Areas:  

Neurological Disease

JNJ-26990990 is a broad-spectrum antiepileptic agent with oral activity. JNJ-26990990 can inhibit voltage-gated Na + channels and N-type Ca 2+ channels, but has a very weak inhibitory effect on human carbonic anhydrase-II (IC50 = 110 μM) .
loading...
    loading...
Cat. No.: HY-B0106S1
CAS No.: 1217851-16-5
Synonyms: UCB L059-d3
Levetiracetam-d3 is the deuterium labeled Levetiracetam. Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent .
loading...
    loading...
Cat. No.: HY-12772R
CAS No.: 112559-91-8
Synonyms: Itraconazole metabolite Hydroxy Itraconazole (Standard); R-63373 (Standard)
Research Areas:  

Others

Levetiracetam (Standard) is the analytical standard of Levetiracetam. This product is intended for research and analytical applications. Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent .
loading...
    loading...
Cat. No.: HY-W016509R
CAS No.: 488-58-4
epi-Inositol (Standard) is the analytical standard of epi-Inositol (HY-W016509). This product is intended for research and analytical applications. epi-Inositol, a inositol analog, is an antidepressant agent. epi-Inositol shows regulatory effects on expression of the most highly regulated gene in the inositol biosynthetic pathway. epi-Inositol shows antiepileptic effect .
loading...
    loading...
Cat. No.: HY-105022R
CAS No.: 104383-17-7
Synonyms: R 58735 (Standard)
Research Areas:  

Neurological Disease

Sabeluzole (Standard) is the analytical standard of Sabeluzole. This product is intended for research and analytical applications. Sabeluzole (R 58735), a benzothiazol derivative, has antiischemic, antiepileptic, and cognitive-enhancing properties. Sabeluzole protects rat hippocampal neurons against NMDA- and glutamate-induced neurotoxicity via preventing tau expression. Sabeluzole enhances memory in rats, and prevents the amnesic effect of Chlordiazepoxide. Sabeluzole can be used fro research of Alzheimer's disease .
loading...
    loading...